

Is Risk-Reducing OS for Ov Ca Overrated?
Jul 8, 2024
Debunking controversial study on ovarian cancer risk reduction, exploring salpingectomy benefits and limitations, differentiating recommendations for general population and BRCA mutation carriers. Discussing origin theory of high-grade serous ovarian cancers, impact of prophylactic surgeries on BRCA carriers, and reviewing key publications.
Chapters
Transcript
Episode notes